BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29713255)

  • 1. Who Really Benefits from 3D-Based Planning of Brachytherapy for Cervical Cancer?
    Ha IB; Jeong BK; Kang KM; Jeong H; Lee YH; Choi HS; Lee JH; Choi WJ; Shin JK; Song JH
    J Korean Med Sci; 2018 Apr; 33(18):e135. PubMed ID: 29713255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Dosimetric Influence of Applicator Displacement on 2D and 3D Brachytherapy for Cervical Cancer Treatment.
    Wu A; Tang D; Wu A; Liu Y; Qian L; Zhu L
    Technol Cancer Res Treat; 2021; 20():15330338211041201. PubMed ID: 34569371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point A vs. HR-CTV D
    Harmon G; Diak A; Shea SM; Yacoub JH; Small W; Harkenrider MM
    Brachytherapy; 2016; 15(6):825-831. PubMed ID: 27693173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric Comparison between Three-Dimensional Magnetic Resonance Imaging-Guided and Conventional Two-Dimensional Point A-Based Intracavitary Brachytherapy Planning for Cervical Cancer.
    Ren J; Yuan W; Wang R; Wang Q; Li Y; Xue C; Yan Y; Ma X; Tan L; Liu Z
    PLoS One; 2016; 11(9):e0161932. PubMed ID: 27611853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The addition of interstitial needles to intracavitary applicators in the treatment of locally advanced cervical cancer: Why is this important and how to implement in low- and middle-income countries?
    Lombe D; Crook J; Bachand F; Moore J; Hamm J; Rose T; Anderson D; Batchelar D
    Brachytherapy; 2020; 19(3):316-322. PubMed ID: 32229073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel two-step optimization method for tandem and ovoid high-dose-rate brachytherapy treatment for locally advanced cervical cancer.
    Sharma M; Fields EC; Todor DA
    Brachytherapy; 2015; 14(5):613-8. PubMed ID: 26092424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of dosimetric parameters in the treatment planning of magnetic resonance imaging-based intracavitary image-guided adaptive brachytherapy with and without optimization using the central shielding technique.
    Nishikawa R; Yoshida K; Ebina Y; Omoteda M; Miyawaki D; Ishihara T; Ejima Y; Akasaka H; Satoh H; Kyotani K; Takahashi S; Sasaki R
    J Radiat Res; 2018 May; 59(3):316-326. PubMed ID: 29518234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of High Risk Clinical Target Volume reduction during Brachytherapy and impact on its coverage in patients with inoperable cervical cancer.
    Pobijakova M; Scepanovic D; Paluga M; Fekete M; Mardiak J
    Neoplasma; 2018 Mar; 65(3):425-430. PubMed ID: 29788726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deformable image registration-based contour propagation yields clinically acceptable plans for MRI-based cervical cancer brachytherapy planning.
    Chapman CH; Polan D; Vineberg K; Jolly S; Maturen KE; Brock KK; Prisciandaro JI
    Brachytherapy; 2018; 17(2):360-367. PubMed ID: 29331573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study.
    Charra-Brunaud C; Harter V; Delannes M; Haie-Meder C; Quetin P; Kerr C; Castelain B; Thomas L; Peiffert D
    Radiother Oncol; 2012 Jun; 103(3):305-13. PubMed ID: 22633469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning study.
    Menon G; Huang F; Sloboda R; Pearcey R; Ghosh S
    Brachytherapy; 2014; 13(6):572-8. PubMed ID: 25085455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
    Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
    Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D CT-based high-dose-rate brachytherapy for cervical cancer: clinical impact on late rectal bleeding and local control.
    Kang HC; Shin KH; Park SY; Kim JY
    Radiother Oncol; 2010 Dec; 97(3):507-13. PubMed ID: 21074881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.
    Liu ZS; Guo J; Zhao YZ; Lin X; Zhang BY; Zhang C; Wang HY; Yu L; Ren XJ; Wang TJ
    Int J Gynecol Cancer; 2017 May; 27(4):768-775. PubMed ID: 28267131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of dose-volume analysis between standard Manchester plan and magnetic resonance image-based plan of intracavitary brachytherapy for uterine cervical cancer.
    Takenaka T; Yoshida K; Tachiiri S; Yamazaki H; Aramoto K; Furuya S; Yoshida M; Ban C; Tanaka E; Honda K
    J Radiat Res; 2012 Sep; 53(5):791-7. PubMed ID: 22843369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric research into target regions and organs at risk in three-dimensional intracavitary brachytherapy techniques for Chinese patients with cervical carcinoma.
    Wu N; Zhao Z; Han D; Cheng G; Zhao H
    J Radiat Res; 2019 Jan; 60(1):124-133. PubMed ID: 30452658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of offline adaptive planning techniques in image-guided brachytherapy of cervical cancer.
    Liu H; Kinard J; Maurer J; Shang Q; Vanderstraeten C; Hayes L; Sintay B; Wiant D
    J Appl Clin Med Phys; 2018 Nov; 19(6):316-322. PubMed ID: 30284370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
    Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C
    Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
    Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
    Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.